RADIUS HEALTH ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of RDUS and Encourages Investors to Contact the Firm
June 24, 2022 23:29 ET
|
Bragar Eagel & Squire
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
Radius Health to Present Data on Abaloparatide at ASBMR 2019 Annual Meeting
September 13, 2019 18:03 ET
|
Radius Health Inc.
WALTHAM, Mass., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced it will present five posters, including results from a real-world study on patient experience,...
Radius Health to Present Two Posters at AACE 2019 Annual Meeting
April 17, 2019 08:00 ET
|
Radius Health Inc.
WALTHAM, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing...
Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting
March 23, 2019 12:45 ET
|
Radius Health Inc.
-Post-hoc analysis suggests abaloparatide may be useful in the treatment of women with postmenopausal osteoporosis and concurrent osteoarthritis, at high risk for fracture- -Preclinical studies...
Radius Health to Present Data on Abaloparatide at ASBMR 2018 Annual Meeting
September 24, 2018 08:00 ET
|
Radius Health Inc.
WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company committed to developing and commercializing...
Radius Health Presents Positive Data for the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection at ENDO 2018 Annual Meeting
March 17, 2018 12:30 ET
|
Radius Health Inc.
WALTHAM, Mass., March 17, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing...
Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection
March 12, 2018 16:30 ET
|
Radius Health Inc.
WALTHAM, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing...
LAVOIE GROUP WINS SILVER AWARD IN THE 26th ANNUAL MERCURY EXCELLENCE AWARDS COMPETITION FOR REBRANDING RADIUS HEALTH, INC.
March 25, 2013 14:15 ET
|
LaVoie Health Science
Cambridge, MA, March 25, 2013 (GLOBE NEWSWIRE) -- LaVoie
Strategic Communications Group, Inc. (LaVoie Group), a firm
with a proven track record of building value for health science
innovations through...